Back
Canaan, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
39
CAN
Canaan, Inc.
Last Price:
$0.94
Seasonality Move:
75.66%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.99
Seasonality Move:
-31.39%
Sell
39
Canaan, Inc. (CAN)
is a Sell
Is Canaan, Inc. a Buy, Sell or Hold?
-
The current Canaan, Inc. [CAN] share price is $0.94. The Score for CAN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CAN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAN Stock Price Chart
What is Canaan, Inc.'s stock price today?
-
The Canaan, Inc. share price today is $0.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAN is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
CAN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 43.54 | Sell |
| Chaikin Money Flow: | -10810739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.9 - 1.14) | Sell |
| Bollinger Bands (100): | (0.66 - 1.34) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 86.01 | Buy |
| Chaikin Money Flow: | 124529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 42.89) | Buy |
| Bollinger Bands (100): | (18.11 - 33.75) | Buy |
CAN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.96 | Sell |
| 20-day SMA: | 0.97 | Sell |
| 50-day SMA: | 1.24 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 0.95 | Sell |
| 20-day EMA: | 1.01 | Sell |
| 50-day EMA: | 1.06 | Sell |
| 200-day EMA: | 0.64 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.44 | Buy |
| 50-day SMA: | 32.1 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 32.59 | Buy |
| 200-day EMA: | 27.3 | Buy |
Canaan, Inc. Earnings Growth & CAN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.17 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.
Canaan, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||